3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Off-the-Shelf, Hybrid, Innominate Chimney Thoracic Endovascular Aneurysm Repair for Treatment of Mycotic Thoracic Aortic Aneurysm: A Case Report

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mycotic thoracic aortic aneurysm (MTAA) is a disease that is difficult to treat and often lethal. Open repair has high morbidity and mortality risks; additionally, thoracic endovascular aneurysm repair (TEVAR) often requires innovative techniques. We report the use of an innominate artery chimney endovascular aneurysm repair (ChEVAR) with carotid-carotid and carotid-left subclavian artery bypass for a time-sensitive Salmonella-related MTAA. A symptomatic type 1a endoleak was discovered and promptly and successfully treated. This report shows that the use of innominate artery ChEVAR to treat MTAA is feasible and safe, although the procedure is rarely performed, even in large series. We hypothesize that prophylactic gutter embolization is a feasible option in view of the high endoleak risks in such cases, although further evidence is required to support this.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Endovascular treatment of mycotic aortic aneurysms: a European multicenter study.

          Mycotic aortic aneurysm (MAA) is a rare and life-threatening disease. The aim of this European multicenter collaboration was to study the durability of endovascular aortic repair (EVAR) of MAA, by assessing late infection-related complications and long-term survival.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Infected aortic aneurysms: clinical outcome and risk factor analysis.

            Infected aortic aneurysms are difficult to treat, and are associated with significant mortality. Hospital survival is poor in patients with severe aortic infection, Salmonella species infection, Staphylococcus aureus infection, aneurysm rupture, and suprarenal aneurysm location. We reviewed the clinical outcome in 46 patients with primary infected aortic aneurysms and identified clinical variables associated with prognosis. Data were collected by means of retrospective chart review. Univariate and multivariate logistic regression models were used for risk factor analysis. Between August 1995 and March 2003, 48 patients with primary infected aortic aneurysms were treated at our hospitals. Two patients with negative culture results were excluded. Of the remaining 46 patients, 35 patients had aortic aneurysms infected with Salmonella species and 11 patients had aortic aneurysms infected with microorganisms other than Salmonella species. There were 20 suprarenal infections and 26 infrarenal infections. Surgical debridement and in situ graft replacement were performed in 35 patients, with an early mortality rate of 11%. The incidence of late prosthetic graft infection was 10%. The 90-day mortality rate in patients operated on was 0% for elective operation and 36% for nonelective operation (P =.006, Fisher exact test). Independent predictors of aneurysm-related death were advanced age, non-Salmonella infection, and no operation. With timely surgical intervention and prolonged antibiotic treatment, in situ graft replacement provides an excellent outcome in patients with primary infected aortic aneurysms and elective operation. Mortality is still high in patients undergoing urgent operation. Advanced age, non-Salmonella infection, and no operation are major determinants of mortality.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Infectious thoracic aortitis: a literature review.

              Infectious thoracic aortitis (IA) remains a rare disease, especially after the appearance of antibiotics. However, if left untreated it is always lethal. It usually affects patients with atherosclerotic aortic disease and/or infective endocarditis. Mycotic aneurysm is the most common form of presentation, although a few reports of nonaneurysmal infectious thoracic aortitis have also been described. Various microorganisms have been associated with infectious thoracic aortitis, most commonly Staphylococcal, Enterococcus, Streptococcus, and Salmonella species. It is extremely important to establish an early diagnosis of IA, because this condition is potentially life-threatening. However, diagnosis is frequently delayed since clinical manifestations are usually nonspecific. Antibiotherapy in combination with complete surgical excision of the infected aorta is the best choice of treatment. Copyright 2009 Wiley Periodicals, Inc.
                Bookmark

                Author and article information

                Journal
                Vasc Specialist Int
                Vasc Specialist Int
                Vascular Specialist International
                The Korean Society for Vascular Surgery
                2288-7970
                2288-7989
                2024
                24 April 2024
                24 April 2024
                : 40
                : 11
                Affiliations
                [1 ]Department of General Surgery, Singapore General Hospital, Singapore
                [2 ]Department of Vascular Surgery, Singapore General Hospital, Singapore
                Author notes
                Corresponding author: Nick Ng Zhi Peng, Department of Vascular Surgery, Singapore General Hospital, Outram Road Singapore 169608, Singapore, Tel: 65-62223322, Fax: 65-62249221, E-mail: nick.ng.z.p@ 123456singhealth.com.sg
                Author information
                https://orcid.org/0000-0002-9889-0608
                https://orcid.org/0000-0001-6730-3637
                https://orcid.org/0000-0002-7892-8568
                Article
                vsi-40-11
                10.5758/vsi.230126
                11056280
                38679430
                c9cbae53-925a-4c5c-83ee-51451fb8f219
                Copyright © 2024, The Korean Society for Vascular Surgery

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 12 December 2023
                : 5 February 2024
                : 17 February 2024
                Funding
                FUNDING None.
                Categories
                Case Report

                mycotic aneurysm,thoracic aortic aneurysm,innominate artery,endovascular aneurysm repair,endoleak

                Comments

                Comment on this article